A Phase Ia/Ib Study of IBI315 in Patients With HER2-expressing Advanced Solid Tumor
Clinical trial NCT04162327 · COMPLETED
Trial details
- NCT number
- NCT04162327
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-26
- Primary completion
- 2022-01-27
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.